Bernd Schnabl
Papers
1
Total Citations
16
H-Index
1
About
Bernd Schnabl is a leading translational researcher whose work bridges hepatology, microbiome science, and biomedical engineering. His primary research areas include liver fibrosis, nonalcoholic steatohepatitis (NASH), and the gut–liver axis, with a focus on developing noninvasive diagnostic tools for preclinical models. Schnabl’s major contribution is the creation of a robotic shear wave elastography (SWE) system that enables precise, noninvasive staging of liver fibrosis in murine models—a technology that overcomes a critical bottleneck in preclinical drug development. His most-cited paper (16 citations) details this system, which adapts clinical SWE for high-throughput, reproducible rodent imaging. This work has significant impact: by providing a quantitative, longitudinal measure of liver stiffness, it allows researchers to track disease progression and therapeutic response without sacrificing animals, accelerating the translation of antifibrotic therapies. Schnabl’s achievements include bridging engineering and hepatology to solve a practical problem, and his system is now being adopted by academic and pharmaceutical labs seeking to replace invasive histology with dynamic, real-time stiffness assessments. His research exemplifies how cross-disciplinary innovation can transform preclinical study design.
Research Focus
Key Achievements
Top Papers
- 1